Cargando…

Impact of systematic screening for AmpC-hyperproducing Enterobacterales intestinal carriage in intensive care unit patients

BACKGROUND: Empirical antimicrobial therapy (EAT) is a challenge for community-acquired, hospital-acquired and ventilator-associated pneumonia, particularly in the context of the increasing occurrence of third-generation cephalosporin-resistant Enterobacterales (3GCR-E), including extended-spectrum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manquat, Elsa, Le Dorze, Matthieu, Pean De Ponfilly , Gauthier, Benmansour, Hanaa, Amarsy, Rishma, Cambau, Emmanuelle, Soyer, Benjamin, Chousterman, Benjamin Glenn, Jacquier, Hervé
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594978/ https://www.ncbi.nlm.nih.gov/pubmed/33119840 http://dx.doi.org/10.1186/s13613-020-00754-9

Ejemplares similares

Correction to: Impact of systematic screening for AmpC-hyperproducing Enterobacterales intestinal carriage in intensive care unit patients
por: Manquat, Elsa, et al.
Publicado: (2021)

Serratia marcescens outbreak in the intensive care unit during the COVID-19 pandemic: A paradoxical risk?
por: Amarsy, R., et al.
Publicado: (2020)

Impact of a 24/7 Rapid Molecular Assay for Influenza Detection on the Prescription of Oseltamivir
por: Jacquier, Hervé, et al.
Publicado: (2020)

Disseminated Mycobacterium chimaera Following Open-Heart Surgery, the Heater–Cooler Unit Worldwide Outbreak: Case Report and Minireview
por: Lecorche, Emmanuel, et al.
Publicado: (2020)

200. Antimicrobial Activity of Ceftazidime-Avibactam and Comparators against AmpC Hyperproducing Enterobacterales and P. aeruginosa Collected from United States (US) Medical Centers (2016-2020)
por: Sader, Helio S, et al.
Publicado: (2021)

Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales
por: Ávila-Núñez, M., et al.
Publicado: (2023)

Bloodstream Infections by AmpC-Producing Enterobacterales: Risk Factors and Therapeutic Outcome
por: Pospišil, Mladen, et al.
Publicado: (2023)

Activity of temocillin against ESBL-, AmpC-, and/or KPC-producing Enterobacterales isolated in Poland
por: Kuch, Alicja, et al.
Publicado: (2020)

Seasonal variations in blood culture numbers and time to positivity and potential impact of reducing incubation periods
por: de Ponfilly, Gauthier Péan, et al.
Publicado: (2021)

Relation between presence of extended-spectrum β-lactamase-producing Enterobacteriaceae in systematic rectal swabs and respiratory tract specimens in ICU patients
por: Carbonne, Hélène, et al.
Publicado: (2017)

Prevalence of ESBL, AmpC and Carbapenemase-Producing Enterobacterales Isolated from Raw Vegetables Retailed in Romania
por: Colosi, Ioana Alina, et al.
Publicado: (2020)

93. Leveraging Stewardship to Promote Narrower-spectrum Antibiotic Use for Low-risk AmpC Enterobacterales
por: Hardy, Megan E, et al.
Publicado: (2023)

In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways
por: Skoglund, Erik, et al.
Publicado: (2018)

Risk Factors of Death in Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacterales in Patients with Neoplasia
por: da Cunha Ferreira, Tiago, et al.
Publicado: (2021)

Occurrence, Typing, and Resistance Genes of ESBL/AmpC-Producing Enterobacterales in Fresh Vegetables Purchased in Central Israel
por: Kon, Hadas, et al.
Publicado: (2023)

Corrigendum to “In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways”
por: Skoglund, Erik, et al.
Publicado: (2019)

Plasmid-Mediated AmpC: Prevalence in Community-Acquired Isolates in Amsterdam, the Netherlands, and Risk Factors for Carriage
por: Reuland, E. Ascelijn, et al.
Publicado: (2015)

Detection of Extended-Spectrum β-Lactamases (ESBLs) and AmpC in Class A and Class B Carbapenemase-Producing Enterobacterales
por: Imkamp, Frank, et al.
Publicado: (2022)

Fecal carriage of extended-spectrum β-lactamases and AmpC-producing Escherichia coli in a Libyan community
por: Ahmed, Salwa Fouad, et al.
Publicado: (2014)

High prevalence of fecal carriage of extended spectrum β-lactamase/AmpC-producing Enterobacteriaceae in cats and dogs
por: Hordijk, Joost, et al.
Publicado: (2013)

Fecal Carriage of Extended-Spectrum β-Lactamase-/AmpC-Producing Escherichia coli in Pet and Stray Cats
por: Ratti, Gabriele, et al.
Publicado: (2023)

Carriage of ESBL/AmpC-producing or ciprofloxacin non-susceptible Escherichia coli and Klebsiella spp. in healthy people in Norway
por: Ulstad, Charlotte R., et al.
Publicado: (2016)

Characterization of Extended-Spectrum β-Lactamase-Producing and AmpC β-Lactamase-Producing Enterobacterales Isolated from Companion Animals in Korea
por: Shin, Se Ra, et al.
Publicado: (2021)

The Frequency of Extended-Spectrum β-Lactamase Genes Harbored by Enterobacterales Isolates at High Risk for Clinically Significant Chromosomal ampC Expression
por: Hareza, Dariusz, et al.
Publicado: (2023)

High Prevalence of Plasmid-Mediated Quinolone Resistance among ESBL/AmpC-Producing Enterobacterales from Free-Living Birds in Poland
por: Furmanek-Blaszk, Beata, et al.
Publicado: (2023)

Database for the ampC alleles in Acinetobacter baumannii
por: Karah, Nabil, et al.
Publicado: (2017)

High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production
por: Kunz Coyne, Ashlan J, et al.
Publicado: (2023)

Multicenter Evaluation of the FilmArray Blood Culture Identification 2 Panel for Pathogen Detection in Bloodstream Infections
por: Caméléna, François, et al.
Publicado: (2022)

Outbreak of NDM-1-producing Klebsiella pneumoniae in the intensive care unit during the COVID-19 pandemic: Another nightmare
por: Amarsy, Rishma, et al.
Publicado: (2021)

Whole Genome Sequencing of Extended-Spectrum- and AmpC- β-Lactamase-Positive Enterobacterales Isolated From Spinach Production in Gauteng Province, South Africa
por: Richter, Loandi, et al.
Publicado: (2021)

Clinical outcome of wild-type AmpC-producing Enterobacterales infection in critically ill patients treated with β-lactams: a prospective multicenter study
por: Mounier, Roman, et al.
Publicado: (2022)

2776. Decrease in ceftriaxone treatment failure rates for infections caused by inducible AmpC producing Enterobacterales associated with changes in laboratory susceptibility testing reporting
por: Khan, Ayesha, et al.
Publicado: (2023)

594. A Multi-Centered Study of the Clinical and Molecular Epidemiology of AmpC Cephalosporinase-Producing (AmpC) Enterobacteriaceae (Ent) Infections in Children
por: Medernach, Rachel L, et al.
Publicado: (2019)

Carriage of Extended-Spectrum-Beta-Lactamase- and AmpC Beta-Lactamase-Producing Escherichia coli Strains from Humans and Pets in the Same Households
por: Toombs-Ruane, Leah J., et al.
Publicado: (2020)

Systematic Review of Plasmid AmpC Type Resistances in Escherichia coli and Klebsiella pneumoniae and Preliminary Proposal of a Simplified Screening Method for ampC
por: Rodríguez-Guerrero, Enrique, et al.
Publicado: (2022)

Early Treatment Outcomes for Bloodstream Infections Caused by Potential AmpC Beta-Lactamase-Producing Enterobacterales with Focus on Piperacillin/Tazobactam: A Retrospective Cohort Study
por: Herrmann, Lena, et al.
Publicado: (2021)

Clinical Outcomes of Third-Generation Cephalosporin Definitive Therapy for Bloodstream Infections Due to Enterobacterales with Potential AmpC Induction: A Single-Center Retrospective Study
por: Vossius, Gilles, et al.
Publicado: (2023)

Controversies about extended-spectrum and AmpC beta-lactamases.
por: Thomson, K S
Publicado: (2001)

Detection of AmpC β Lactamases in Gram-negative Bacteria
por: Gupta, Gunjan, et al.
Publicado: (2014)

Challenges in detection of AmpC β-lactamases among Enterobacteriaceae
por: Joseph, Noyal Mariya, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_o0rp4cip8rvvhv0tquebmbrgca